BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 37710339)

  • 1. The mesocortical dopaminergic system cannot explain hyperactivity in an animal model of attention deficit hyperactivity disorder (ADHD)- Spontaneously hypertensive rats (SHR).
    Gungor Aydin A; Adiguzel E
    Lab Anim Res; 2023 Sep; 39(1):20. PubMed ID: 37710339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADHD pathogenesis in the immune, endocrine and nervous systems of juvenile and maturating SHR and WKY rats.
    Kozłowska A; Wojtacha P; Równiak M; Kolenkiewicz M; Huang ACW
    Psychopharmacology (Berl); 2019 Oct; 236(10):2937-2958. PubMed ID: 30737597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theobromine improves hyperactivity, inattention, and working memory
    Matsuzaki K; Sugimoto N; Hossain S; Islam R; Sumiyoshi E; Hashimoto M; Kishi H; Shido O
    Food Funct; 2024 May; 15(10):5579-5595. PubMed ID: 38713055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The usefulness of the spontaneously hypertensive rat to model attention-deficit/hyperactivity disorder (ADHD) may be explained by the differential expression of dopamine-related genes in the brain.
    Li Q; Lu G; Antonio GE; Mak YT; Rudd JA; Fan M; Yew DT
    Neurochem Int; 2007 May; 50(6):848-57. PubMed ID: 17395336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droxidopa alters dopamine neuron and prefrontal cortex activity and improves attention-deficit/hyperactivity disorder-like behaviors in rats.
    Dela Peña I; Shen G; Shi WX
    Eur J Pharmacol; 2021 Feb; 892():173826. PubMed ID: 33347825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered dopaminergic function in the prefrontal cortex, nucleus accumbens and caudate-putamen of an animal model of attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell V; de Villiers A; Sagvolden T; Lamm M; Taljaard J
    Brain Res; 1995 Apr; 676(2):343-51. PubMed ID: 7614004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.
    Russell VA
    Behav Brain Res; 2002 Mar; 130(1-2):191-6. PubMed ID: 11864734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens.
    Miller EM; Pomerleau F; Huettl P; Russell VA; Gerhardt GA; Glaser PE
    Neuropharmacology; 2012 Dec; 63(8):1327-34. PubMed ID: 22960443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of Dopamine D1-like Receptor Pathways of GABAergic Interneurons in the Anterior Cingulate Cortex of Spontaneously Hypertensive Rats.
    Satoh H; Suzuki H; Saitow F
    Neuroscience; 2018 Dec; 394():267-285. PubMed ID: 30394321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and genetic evidence for a novel animal model of Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype.
    Sagvolden T; Dasbanerjee T; Zhang-James Y; Middleton F; Faraone S
    Behav Brain Funct; 2008 Dec; 4():56. PubMed ID: 19046438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.
    Soeters HS; Howells FM; Russell VA
    Metab Brain Dis; 2008 Sep; 23(3):303-14. PubMed ID: 18665438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvalbumin interneuron deficiency in the prefrontal and motor cortices of spontaneously hypertensive rats: an attention-deficit hyperactivity disorder animal model insight.
    Bogdańska-Chomczyk E; Równiak M; Huang AC; Kozłowska A
    Front Psychiatry; 2024; 15():1359237. PubMed ID: 38600979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing and delay discounting in attention-deficit/hyperactivity disorder: A translational approach.
    Fox AE; Nicholson AM; Singha D; Thieret BAS; Ortiz M; Visser EJ
    Dev Psychobiol; 2023 Jul; 65(5):e22399. PubMed ID: 37338253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.
    Roessner V; Sagvolden T; Dasbanerjee T; Middleton FA; Faraone SV; Walaas SI; Becker A; Rothenberger A; Bock N
    Neuroscience; 2010 Jun; 167(4):1183-91. PubMed ID: 20211696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder--lack of effect of methylphenidate.
    Warton FL; Howells FM; Russell VA
    Metab Brain Dis; 2009 Dec; 24(4):599-613. PubMed ID: 19821016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalin regulates the dopamine system to control the core symptoms of ADHD.
    Zhou R; Wang J; Han X; Ma B; Yuan H; Song Y
    Mol Brain; 2019 Feb; 12(1):11. PubMed ID: 30736828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Rat Model of ADHD-like Hyperactivity/Impulsivity after Delayed Reward Has Selective Loss of Dopaminergic Neurons in the Right Ventral Tegmental Area.
    Kohe SE; Gowing EK; Seo S; Oorschot DE
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional profiling of SHR/NCrl prefrontal cortex shows hyperactivity-associated genes responsive to amphetamine challenge.
    Dela Peña IJI; Dela Peña I; de la Peña JB; Kim HJ; Sohn A; Shin CY; Han DH; Kim BN; Ryu JH; Cheong JH
    Genes Brain Behav; 2017 Sep; 16(7):664-674. PubMed ID: 28422445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder.
    Somkuwar SS; Kantak KM; Dwoskin LP
    J Neurosci Methods; 2015 Aug; 252():55-63. PubMed ID: 25680322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain.
    Wu L; Zhao Q; Zhu X; Peng M; Jia C; Wu W; Zheng J; Wu XZ
    Brain Pathol; 2010 Nov; 20(6):1042-54. PubMed ID: 20557304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.